Meet Dr. Noah Cohen, Surgical Oncologist | NYU Langone Health

Why It Matters

NYU Langone’s expertise and research pipeline give patients with rare abdominal cancers access to life‑saving, minimally invasive treatments and novel therapies, setting new standards in oncologic care.

Key Takeaways

• Dr. Cohen treats stomach, retroperitoneal sarcoma, peritoneal malignancies.
• Early symptoms include weight loss, eating difficulty, abdominal bloating.
• Emphasizes clear communication and family‑centered care throughout treatment.
• NYU Langone offers robotic gastric surgery and leading HIPEC program.
• He designs early‑phase trials to advance treatment options for rare cancers.

Summary

The video introduces Dr. Noah Cohen, a surgical oncologist at NYU Langone Health who specializes in stomach cancer, retroperitoneal sarcomas, and peritoneal surface malignancies. He explains that these cancers often present with vague signs such as unintentional weight loss, difficulty eating, and abdominal bloating, urging patients to seek medical evaluation promptly. Dr. Cohen highlights NYU Langone’s advanced treatment arsenal: minimally invasive, robotic‑assisted gastrectomies for gastric cancer and one of the nation’s largest cytoreductive surgery and HIPEC programs for peritoneal malignancies. He also stresses the institution’s multidisciplinary approach and its active participation in early‑phase clinical trials aimed at developing next‑generation therapies. Drawing on personal experience with family members who battled cancer, Dr. Cohen emphasizes a treatment philosophy rooted in clear communication and treating patients and their families as if they were his own loved ones. He believes empowering patients through transparent dialogue improves outcomes and eases the emotional burden of a new diagnosis. The implications are twofold: patients gain access to cutting‑edge surgical techniques and innovative trial options, while the broader oncology community benefits from data generated at a high‑volume center. Dr. Cohen’s dual role as clinician and researcher positions NYU Langone as a leader in tackling rare abdominal cancers.

Original Description

Stomach cancer. Retroperitoneal sarcomas. Peritoneal surface malignancies. These are some of the rarest — and most complex — cancers a surgeon can treat.

Dr. Noah Cohen is a surgical oncologist at NYU Langone Health specializing in exactly these cancers. Many of them don't announce themselves with obvious symptoms, which makes knowing

what to watch for critical.

Symptoms that should prompt a visit to your doctor:

→ Unintentional weight loss

→ Difficulty eating

→ Abdominal bloating

At NYU Langone Health, Dr. Cohen and his team perform cutting-edge robotic-assisted surgery for gastric cancer, one of the most minimally invasive approaches available. For peritoneal surface malignancies, NYU Langone is home to one of the largest cytoreductive surgery and HIPEC centers

in the nation, offering patients multidisciplinary care and access to clinical trials.

Dr. Cohen is also actively involved in designing early-phase clinical trials to develop the next generation of treatments for patients with these cancers.

His approach: treat every patient and their family as if they were his own because he knows firsthand what a cancer diagnosis means for everyone it touches.

─────────────────────────────

ABOUT DR. NOAH COHEN

─────────────────────────────

Surgical Oncologist · NYU Langone Health

Specialties: Gastric cancer, retroperitoneal sarcomas, peritoneal surface malignancies, HIPEC, robotic-assisted surgery, early-phase clinical trials

📍 Learn more and request an appointment:

https://nyulangone.org/doctors/1780901918/noah-a-cohen

─────────────────────────────

#SurgicalOncology #StomachCancer #GastricCancer

#NYULangoneHealth #CancerCare #HIPEC #RoboticSurgery

#PeritonealCancer #CancerTreatment #OncologyNYC